Digital mental-health apps — FDA-approved Somryst (insomnia) and EndeavorRx (ADHD), Korea's MindFitness, the reality and limits of the "DTx (digital therapeutics)" era

Digital mental-health apps — FDA-approved Somryst (insomnia) and EndeavorRx (ADHD), Korea's MindFitness, the reality and limits of the "DTx (digital therapeutics)" era

The 2020s ushered in the era of Digital Therapeutics (DTx). The FDA began approving prescription digital mental-health apps: Somryst (CBT-I for insomnia, 2020), EndeavorRx (game-based ADHD, 2020), Rejoyn (depression, 2024), Reset (substance use disorder, 2017). Korea's MFDS approved its first DTx, "Somzz" (insomnia), in 2023. Meta-analysis (Linardon 2019 JAMA Psychiatry, 78 RCTs): digital CBT achieves 70–80% of in-person CBT efficacy at 1/10 the cost and far greater accessibility. Evidence-validated domains: insomnia, depression, anxiety, ADHD, substance use disorder. Limits: 1) not for severe depression / suicidality alone, 2) 30–50% attrition, 3) limited Korean content, 4) not insurance-covered, 5) data-protection concerns. Best uses: primary-care adjunct, mild depression / anxiety, CBT learning tool. Korean app recommendations and usage guide + how to spot fake "mental coaching" apps.

TL;DR

DTx FDA approvals: Somryst, EndeavorRx, Rejoyn, etc. Digital CBT achieves 70–80% of in-person efficacy at 1/10 cost (Linardon 2019 meta). Korea's Somzz (insomnia) approved 2023. Limits: not for severe cases, 30–50% attrition, limited Korean content, no insurance. Best for mild depression / anxiety, CBT learning, while waiting for an appointment. In crisis: human clinician, 1577-0199.

1. What is "Digital Therapeutics (DTx)"?

Per the Digital Therapeutics Alliance: "clinically validated software that delivers a therapeutic intervention directly to patients". Not generic "meditation apps" — passed clinical trials, regulatory approval (FDA, MFDS). Prescribable by physicians.

2. Major FDA-approved mental-health DTx

AppIndicationApprovalEvidence
Somryst (Pear Therapeutics)Chronic insomnia2020 FDARCT insomnia score -45% at 9 weeks (Forsell 2019)
EndeavorRx (Akili)Attention in ADHD ages 8–122020 FDASTARS-ADHD RCT (Lancet Digital Health 2020)
Rejoyn (Otsuka)Major depressive disorder adjunct2024 FDAMIRAI RCT 6-week depression ↓
Reset / Reset-O (Pear)Substance use disorder2017 / 2018 FDA12-week abstinence retention ×1.6
Wysa, WoebotCBT chatbots (mental-health adjunct)Non-prescription, FDA "low risk"Mild depression / anxiety effects (Fitzpatrick 2017)

3. Digital CBT efficacy — meta-analysis

Linardon et al. (2019) JAMA Psychiatry, 78 RCT meta:

  • Digital CBT vs no-treatment control — effect size (Cohen's d) 0.5–0.7
  • Digital CBT vs in-person CBT — effect-size difference 0.1–0.2 (digital ~70–80% of in-person)
  • Largest effects: insomnia, depression, anxiety
  • Cost: in-person CBT 100,000–150,000 KRW per session vs digital 20,000–50,000 KRW/month

4. Korean digital mental-health apps

AppTargetFeaturesNotes
Somzz (AIMMED)InsomniaKorea's first MFDS-approved DTx (2023)Requires physician prescription; 6-week program
MindFitness (Hueneverse)Depression / anxiety / stressCBT-based; counselor link optionNot MFDS-approved; self-care
MaeumGarden (Korean Psychological Association)Mild depressionKorean free CBTResearch-based
ColikiMeditation / sleepKorean guided meditationGeneral meditation app
MaboMindfulness meditationEarly Korean meditation appBeginner-friendly
Welly's / othersVariousSeveral Korean startupsVarying clinical validation

5. Usage guidelines

Appropriate for

  • Mild–moderate depression / anxiety (PHQ-9 5–14)
  • Insomnia (PSQI > 5)
  • Waiting for psychiatry (avg 2–6 weeks in Korea)
  • Psychotherapy "homework" tool
  • CBT learning (self-understanding)

Do NOT use alone (see a clinician)

  • Severe depression (PHQ-9 ≥ 20)
  • Suicidal ideation / plan / attempt
  • Psychosis (hallucinations, delusions)
  • Bipolar / manic
  • Eating disorders, self-harm
  • Severe PTSD, dissociation

6. 7 criteria to spot a "good app"

  1. Published trial results: RCT papers linked from the company site
  2. Stated therapy model: CBT, DBT, ACT, EMDR — recognized models
  3. Licensed clinician involvement: physicians, clinical psychologists advising
  4. Crisis-resource guidance: 1577-0199 etc. displayed for suicidal thoughts
  5. Privacy policy: clear data use / sharing
  6. MFDS / FDA approval or society endorsement
  7. Korean content: not just a translation; cultural adaptation

7. Signs of fraudulent / harmful apps

  • "Cure depression instantly" / "100% effective" ads
  • Coaches with "mental coach" / "life coach" certificates (no medical credential)
  • Expensive packages pushed (millions of KRW)
  • Astrology / MBTI / fate combinations
  • Anonymous / overseas servers, unclear data protection
  • Forcing drugs / procedures (unlicensed "oriental / natural healing")

8. Insurance and cost

Most Korean digital mental-health apps aren't covered by health insurance. Somzz has partial coverage with prescription (2024 pilot). General apps:

  • Free: Wysa (English chatbot), MaeumGarden (Korean society)
  • 10,000–50,000 KRW/month: MindFitness, Woebot, Calm
  • Bundled with professionals: 100,000–300,000 KRW/month (price of 1–2 in-person sessions)

9. Integrated use with clinic care

Most effective use: 1) self-learning while waiting for the clinic, 2) sharing app results with the physician at the appointment, 3) clinician prescribing the app as "homework", 4) medication + app + regular visits integrated. 25% of Korean psychiatrists recommend apps to patients (2024 survey).

10. In crisis — not a digital app; a human

For suicidal thoughts or serious crisis, do NOT rely on chatbots / apps — go to humans immediately (1577-0199, 1393, ER, 112). There are cases of chatbots responding inappropriately to suicidal thoughts (2023 Replika incident). Human physicians, nurses, and counselors are decisive.

Ad

Frequently asked questions

Can digital apps replace psychiatrists?

No. Meta-analysis shows digital reaches 70–80% of in-person efficacy — it's an adjunct. Severe cases, suicidality, psychosis, and medication assessment require a human clinician. Digital is best for "between visits", "mild", and "learning adjunct".

Can I use AI chatbots (ChatGPT) for mental-health counseling?

Cautiously. General ChatGPT lacks medical credentials and clinical validation. Some responses are unsafe (inappropriate to suicidal thoughts). Medical-purpose chatbots (Wysa, Woebot, Replika mental-health mode) have safety guidelines but still limits. In acute crisis: a human.

How do you get a "prescribed digital therapeutic" in Korea?

Somzz (insomnia) was the first case in 2024. Psychiatrists and sleep-clinic physicians can prescribe. Pilot at some university hospitals and specialty clinics. More DTx approvals are expected — depression / anxiety DTx in Korea likely within 5 years.

Related reads

Mental health

Fifty Years of the Bystander Effect: Reassessing Darley·Latané (1968) with Philpot (2020)

9 min read
Mental health

The Science of Hoarding Disorder: Frost, Steketee, and the DSM-5 Standalone Diagnosis

9 min read
Mental health

Why Worry Won't Stop: Borkovec's Cognitive Avoidance Theory and the Science of GAD

9 min read
Mental health

The Stranger in the Mirror: Clark-Wells Cognitive Model of Social Anxiety and CT-SAD

9 min read